Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,984
41 years, by papers

Newest first

3,251 to 3,300 of 3,984

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.

    Metabolism: clinical and experimental2010PMID 20015525

  • Metformin influence on hormone levels at birth, in PCOS mothers and their newborns.

    Human reproduction (Oxford, England)2010PMID 20023292

  • Metformin compared with glyburide in gestational diabetes: a randomized controlled trial.

    Obstetrics and gynecology2010PMID 20027034

  • Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.

    Radiology2010PMID 20032157

  • Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects.

    International journal of clinical pharmacology and therapeutics2010PMID 20040339

  • The use of metformin in type 1 diabetes: a systematic review of efficacy.

    Diabetologia2010PMID 20057994

  • Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy.

    Diabetes care2010PMID 20067974

  • Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes.

    Diabetes, obesity & metabolism2010PMID 20070351

  • Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study.

    Fertility and sterility2010PMID 20079899Indexed under metformin in PubMed's chemical list

  • Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1.

    PloS one2010PMID 20090912

  • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

    The Cochrane database of systematic reviews2010PMID 20091535

  • Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

    The Cochrane database of systematic reviews2010PMID 20091537

  • Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.

    Diabetes, obesity & metabolism2010PMID 20092585Indexed under metformin in PubMed's chemical list

  • Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial.

    American journal of obstetrics and gynecology2010PMID 20096821

  • Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin.

    Diabetes care2010PMID 20107105

  • Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up.

    Archives of pediatrics & adolescent medicine2010PMID 20124139

  • Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.

    Gynecological endocrinology2010PMID 20148739

  • Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway.

    Kidney international2010PMID 20164825

  • Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study.

    International journal of obesity (2005)2010PMID 20179669

  • Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program.

    Obesity (Silver Spring, Md.)2010PMID 20186137

  • Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study.

    Fertility and sterility2010PMID 20189560

  • Metformin's effect on exercise and postexercise substrate oxidation.

    International journal of sport nutrition and exercise metabolism2010PMID 20190353

  • Severe metabolic acidosis secondary to coadministration of creatine and metformin, a case report.

    The American journal of emergency medicine2010PMID 20223410Indexed under metformin in PubMed's chemical list

  • Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial.

    Fertility and sterility2010PMID 20226444Indexed under metformin in PubMed's chemical list

  • Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.

    Endocrine practice2010PMID 20350924

  • [Antihypertensive effect of metformin in essential hypertensive patients with hyperinsulinemia.].

    Zhonghua nei ke za zhi2010PMID 20356474Also indexed under metformin as a PubMed major topic

  • Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome.

    Fertility and sterility2010PMID 20356587

  • Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study.

    Diabetes care2010PMID 20357372

  • Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.

    Diabetes, obesity & metabolism2010PMID 20380653Indexed under metformin in PubMed's chemical list

  • Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes.

    JAMA2010PMID 20388897

  • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

    The Cochrane database of systematic reviews2010PMID 20393934

  • The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy.

    Diabetes care2010PMID 20413513

  • Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial beta-cell protection in individuals with type 2 diabetes.

    Diabetes, obesity & metabolism2010PMID 20415692

  • Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes.

    Diabetes, obesity & metabolism2010PMID 20415693

  • Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial.

    Lancet (London, England)2010PMID 20417856

  • PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene.

    Human reproduction (Oxford, England)2010PMID 20435692

  • The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis.

    The Journal of clinical psychiatry2010PMID 20441727

  • Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.

    Primary care diabetes2010PMID 20444662

  • Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study.

    International journal of clinical practice2010PMID 20456211

  • Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial.

    BMJ (Clinical research ed.)2010PMID 20488910

  • Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months.

    Gynecological endocrinology2010PMID 20500100

  • Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus.

    Clinical science (London, England2010PMID 20509857

  • A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study.

    Diabetic medicine2010PMID 20536495

  • Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study.

    Diabetic medicine2010PMID 20536952

  • Metformin compared with glyburide for the management of gestational diabetes.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2010PMID 20542272

  • Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.

    Lancet (London, England)2010PMID 20580422

  • Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.

    Current medical research and opinion2010PMID 20583949

  • Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin.

    Schizophrenia research2010PMID 20591628

  • Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.

    Lancet (London, England)2010PMID 20605202

  • Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial.

    Lancet (London, England)2010PMID 20609968Indexed under metformin in PubMed's chemical list

The next 50 papers

← Previous 50